Pharmacokinetics and Safety of Icotinib Hydrochloride Cream in Patients with Mild to Moderate Chronic Plaque Psoriasis: A Randomized Double-Blind Vehicle-Controlled Phase 1 Study

Figure 3

Target plaque photographs at baseline and weeks 1, 2, and 4 in a patient receiving vehicle (a) and 2% icotinib cream (b). Icotinib cream was applied to the left waist: Target Plaque Severity Score (TPSS) at baseline = 8, at week 4 = 3 (-62.5%). Vehicle was applied to the abdomen: TPSS at baseline = 7, at week 4 = 6 (-14.3%).

(a)

(b)